ERA is in the process of being migrated to Scholaris, a Canadian shared institutional repository service (https://scholaris.ca). Deposits and changes to existing ERA items and collections are frozen until migration is complete. Please contact erahelp@ualberta.ca for further assistance
- 217 views
- 240 downloads
The Effects of Docosahexaenoic Acid (DHA) Dietary Supplementation in a Mouse Model of Stargardt-like Macular Dystrophy (STGD3)
-
- Author / Creator
- Hong, Mandy
-
Underlying mechanisms of how docosahexaenoic acid (DHA) might impact the progression of macular degeneration are unknown. We relied on the ELOVL4 mouse model of juvenile macular degeneration, STGD3, to test the hypothesis that antenatal DHA dietary supplementation (2% w/w of total fatty acid) would slow down the progression of retinal degeneration as evidenced by preserved function, anatomy, and DHA levels. DHA+, DHA-, and chow diets commenced antenatally. Retina function was assessed by electroretinogram at 1 and 3 months, while anatomical integrity and fatty acid profiles were assessed with cross-sectional staining and UPLC/MS/MS, respectively, at 3 months. Results showed a negative ELOVL4 genotype effect on rod function, photoreceptor numbers, and DHA/AA levels. Surprisingly, in transgenic retinas DHA supplementation resulted in lower DHA levels compared to non-supplemented. Although beneficial effects of DHA have been reported, antenatal and 3 month postnatal supplementation is not sufficient to elicit these effects in mice with STGD3.
-
- Subjects / Keywords
-
- Graduation date
- Fall 2013
-
- Type of Item
- Thesis
-
- Degree
- Master of Science
-
- License
- This thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for non-commercial purposes. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.